TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Alexion Pharma Nordics AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
42,245
|
180,897
|
174,782 |
| Financial expenses |
171
|
1,208
|
27 |
| Earnings before taxes |
4,129
|
8,370
|
5,206 |
| EBITDA |
3,050
|
8,280
|
4,863 |
| Total assets |
61,647
|
118,565
|
71,930 |
| Current assets |
61,026
|
118,565
|
71,930 |
| Current liabilities |
42,823
|
81,872
|
41,245 |
| Equity capital |
18,824
|
36,693
|
30,685 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
30.5%
|
30.9%
|
42.7% |
| Turnover per employee |
2,640
|
12,921
|
11,652 |
| Profit as a percentage of turnover |
9.8%
|
4.6%
|
3.0% |
| Return on assets (ROA) |
7.0%
|
8.1%
|
7.3% |
| Current ratio |
142.5%
|
144.8%
|
174.4% |
| Return on equity (ROE) |
21.9%
|
22.8%
|
17.0% |
| Change turnover |
-132,669
|
5,215
|
18,305 |
| Change turnover % |
-76%
|
3%
|
12% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.